Author

Hannes M. Schröder

Observed names: Hannes Schröder, Schröder, Hannes M.

Institution: Rheacell (Germany)

Observed institution: Rheacell (Germany)

ORCID: 0000-0002-0427-5867

Observed ORCID: 0000-0002-0427-5867

OpenAlex ID: A5021896307

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

2022 · Andreas Kerstan, Kathrin Dieter, et al. · Stem Cell Research & Therapy · 82

In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials

2019 · Nils Tappenbeck, Hannes M. Schröder, et al. · Cytotherapy · 55

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

2020 · Andreas Kerstan, Elke Niebergall-Roth, et al. · Cytotherapy · 48

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

2021 · Andreas Kerstan, Kathrin Dieter, et al. · JID Innovations · 41

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

2021 · Alexandra Norrick, Jasmina Esterlechner, et al. · Stem Cell Research & Therapy · 38

New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Deficiency: Review from the European Vision Institute Special Interest Focus Group Meeting

2020 · Simona L. Schlereth, Deniz Hos, et al. · Ophthalmic Research · 23

Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues

2023 · Hannes M. Schröder, Elke Niebergall-Roth, et al. · Cells · 9

Works count: 14

Citation count: 296

H-index: 7

I10-index: 6